
Sign up to save your podcasts
Or
Blunt Business explores the critical issues facing the cannabis industry, focusing on regulation, compliance, and investment, through the lens of the International Cannabis Bar Association (INCBA). David Ruskin, their newly appointed president, shared his insights on the organization's role and the evolving legal and regulatory landscape.
Ruskin highlighted the INCBA's value as a network of experienced professionals dedicated to navigating the complexities of cannabis law. He emphasized the organization's role in providing access to expertise on diverse regulatory standards across different markets, a crucial benefit given the ever-changing rules governing the industry.
The INCBA serves as a central resource for staying informed and connected, offering guidance on navigating the intricate regulatory environment. The conversation addressed the ongoing process of rescheduling cannabis under the Controlled Substances Act.
Ruskin discussed the delays caused by new allegations and the subsequent public comment period, including an interlocutory appeal that further complicates the timeline. The potential impact of the Biden administration's support for rescheduling was explored, along with the possibility of increased DEA involvement in cannabis regulation following rescheduling.
4.1
3939 ratings
Blunt Business explores the critical issues facing the cannabis industry, focusing on regulation, compliance, and investment, through the lens of the International Cannabis Bar Association (INCBA). David Ruskin, their newly appointed president, shared his insights on the organization's role and the evolving legal and regulatory landscape.
Ruskin highlighted the INCBA's value as a network of experienced professionals dedicated to navigating the complexities of cannabis law. He emphasized the organization's role in providing access to expertise on diverse regulatory standards across different markets, a crucial benefit given the ever-changing rules governing the industry.
The INCBA serves as a central resource for staying informed and connected, offering guidance on navigating the intricate regulatory environment. The conversation addressed the ongoing process of rescheduling cannabis under the Controlled Substances Act.
Ruskin discussed the delays caused by new allegations and the subsequent public comment period, including an interlocutory appeal that further complicates the timeline. The potential impact of the Biden administration's support for rescheduling was explored, along with the possibility of increased DEA involvement in cannabis regulation following rescheduling.
594 Listeners
12,629 Listeners
24 Listeners
12 Listeners
32,489 Listeners
10 Listeners
567 Listeners
21 Listeners
122 Listeners
13 Listeners
3 Listeners
364,914 Listeners
6 Listeners
50 Listeners
2 Listeners
68 Listeners
51 Listeners
104 Listeners
325 Listeners
213 Listeners
7 Listeners
1,617 Listeners
7 Listeners
12 Listeners